Milford-based biotech company Waters Corp. will merge with Becton, Dickinson and Co.’s biosciences an diagnostic solutions ...

Waters and BD will merge biosciences and diagnostics in a $17.5B deal via Reverse Morris Trust, creating a life sciences ...

Shares of Waters Corporation (NYSE:WAT) declined 2.2% following the announcement of a $17.5 billion Reverse Morris Trust deal ...

BD has found a new home for its biosciences and diagnostics divisions at the lab equipment maker Waters Corporation, through ...

Lab equipment maker Waters Corp on Monday said it will buy a bioscience and diagnostics unit spun off from medtech provider ...

The transaction, approved by both companies' boards of directors, is expected to close by the end of the first quarter of ...

BD and Waters announced an agreement to create a new life science and diagnostics leader through a business combination.

Waters said it reached a deal to buy the Biosciences & Diagnostic Solutions business of Becton Dickinson for around $17.5 ...

The BD business will be spun off and merged with a Waters subsidiary. Waters shares were down about 11% in early trading ...

BDX collaborates with Waters in a $17.5B deal to form a diagnostics powerhouse targeting $9B in revenues by 2030.

Waters Corporation is merging with BD’s Biosciences and Diagnostic Solutions business in a $17.5 billion deal to expand its capabilities in life sciences and diagnostics.

In a strategic play poised to reshape the diagnostics and life sciences landscape, Waters Corp. and Becton Dickinson and Co. ...